Kamalesh Rao

Founder & CEO

Kamalesh has over twenty years of experience in drug discovery and development of pharmaceuticals and product approvals. He has directed the chemical development of over 10 new chemical entities and played a pivotal role in the chemical development of Probuphine, the first ever implantable formulation to deliver long-lasting medication to treat people addicted to opioids, both approved by USFDA. Kamalesh has a BS in chemistry, BS in pharmaceutical technology from the Institute of Chemical Technology, Mumbai, and a MS from University of Oklahoma. He is an avid hiker, enjoys learning new languages and has been a resident of the San Francisco Bay Area since 1995.